Iranian Company Produces Nano-Based Drug to Treat Cancer
‘Nano Daroo Pazhuhan Pardis’ company has produced the medicine which is an albumin-bound paclitaxel and can be typically used for the treatment of different cancers like the breast, pancreatic, ovarian and lung cancers.
The drug is an efficient natural anti-cancer agent inhabiting the growth of cancer cells with no side-effects unlike other solvent-based chemotherapy counterparts.
The addition of albumin nanocarrier to the paclitaxel has led to higher anti-cancer efficiency and considerable penetration of nanocarriers into the tumor tissue
The drug can be used for treatment of tumors in breast, pancreatic, ovarian, and lung cancers.
In another development earlier this year, researchers at a knowledge-based company in Iran launched producing nano injection of ferrous sulfate iron supplements based on the Swiss-type formulation to treat cases of iron deficiency anemia.
Mehdi Roohi Razeliqi, the managing director of an Iranian knowledge-based company, told Iranian media that his company's drug is an iron injection supplement containing iron nanoparticles.
He said that this medicinal product is produced only in a Swiss company which is highly effective in treating the illness.
He said that iron medicine have been imported into the country for several years, noting that as the country is under sanctions, supplying the imported iron injection faces restrictions.
He added that importing the injection costs the country $ 5 million each year.
He went on to say that the iron injection supplements come with advantages over other types of the iron drugs.
Roohi stated that this drug is prescribed for people suffering from anemia and this product is highly effective in reducing the severity of the disease.
“In this company, we achieved the formulation of 10 mg vials containing iron nanoparticles and the produced drug is slow release,” he asserted.
4155/v
